Translational quality control by trans-editing domains

通过转编辑域控制翻译质量

基本信息

  • 批准号:
    10206957
  • 负责人:
  • 金额:
    $ 38.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-17 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Summary Aminoacyl-tRNA synthetases (ARSs) establish the rules of the genetic code, whereby each amino acid is attached to a cognate tRNA. Errors in this process lead to mistranslation, which can be toxic to cells. Recent studies suggest that the selective forces exerted by cell-specific requirements and environmental conditions potentially shape quality control mechanisms. Approximately half of the ARSs possess a proofreading (or editing) function to hydrolyze mischarged aa-tRNAs and evidence that non-proteinaceous amino acids pose the greatest threat to fidelity is beginning to emerge. Early work in the Musier-Forsyth lab in the field of translational quality control focused on our discovery of Class II prolyl-tRNA synthetase (ProRS) editing. This led to a detailed mechanistic understanding of the novel bacterial ProRS posttransfer editing domain (INS) and the demonstration that the INS domain, when purified on its own outside the context of the ARS, was fully functional in tRNA deacylation. We subsequently discovered that single-domain INS homologs are widespread in Bacteria and in recent years, our focus in this area has turned almost entirely to understanding the function of these INS-like domains in tRNA editing. However, many open questions regarding the physiological function of these putative trans-editing proteins remain. The overarching goal of the research described in this MIRA application is to uncover the specific functions of a growing family of trans-editing proteins known as the INS superfamily. This diverse yet universally conserved family now has a solid and accumulating in vitro structure-function knowledge base, which strongly supports a role in maintaining translational fidelity. Our knowledge of the broader physiological roles of these proteins, especially in eukaryotes, is still in its infancy and is just beginning to reveal wider roles than previously anticipated. This major gap will be addressed in this work. While classical knock- down screens that only define essential versus non-essential genes do not immediately identify editing domains as essential, the strong conservation of these domains implies they play important, and in most cases still undiscovered, roles in cell survival and competitiveness. Proposed studies are designed to address some of the many open questions with regard to both physiological trans-editing functions and potential moonlighting functions of the INS superfamily. These domains are largely unexplored in eukaryotes, including a novel sub- family cluster that is encoded in many unicellular eukaryotic pathogens. The therapeutic potential of trans-editing domains has not been exploited and represents another major gap in the field that we hope to address by our planned studies. In the long term, combining drugs that target novel translational fidelity mechanisms along with known ribosome-targeting protein synthesis inhibitors such as aminoglycosides, may results in more effective therapeutic strategies.
概括 氨酰-tRNA 合成酶 (ARS) 建立了遗传密码的规则,其中每个氨基酸都是 连接到同源 tRNA。这个过程中的错误会导致翻译错误,这可能对细胞有毒。最近的 研究表明,细胞特异性要求和环境条件所施加的选择力 潜在地形成质量控制机制。大约一半的 ARS 拥有校对(或编辑)功能 水解错误带电的 aa-tRNA 的功能以及非蛋白质氨基酸构成最大的证据 对忠诚度的威胁开始出现。 Musier-Forsyth 实验室在翻译质量领域的早期工作 控制重点是我们发现的 II 类脯氨酰-tRNA 合成酶 (ProRS) 编辑。这导致了详细的 对新型细菌 ProRS 转移后编辑域 (INS) 的机制理解和演示 INS 结构域在 ARS 环境之外单独纯化时,在 tRNA 中具有完全功能 脱酰基化。我们随后发现单域 INS 同源物广泛存在于细菌和 近年来,我们在这一领域的重点几乎完全转向了解这些类 INS 的功能 tRNA 编辑中的结构域。然而,关于这些假定的生理功能的许多悬而未决的问题 反式编辑蛋白仍然存在。 MIRA 应用程序中描述的研究的总体目标是 揭示不断增长的反式编辑蛋白家族(称为 INS 超家族)的特定功能。这 多样化但普遍保守的家族现在拥有扎实且不断积累的体外结构功能知识 基础,它强烈支持维持翻译保真度的作用。我们的知识更广泛 这些蛋白质的生理作用,特别是在真核生物中,仍处于起步阶段,刚刚开始揭示 角色比之前预期的更广泛。这项工作将解决这一重大差距。虽然古典敲门- 仅定义必需基因与非必需基因的筛选不能立即识别编辑域 至关重要的是,这些领域的强有力的保护意味着它们发挥着重要作用,并且在大多数情况下仍然 尚未发现,在细胞生存和竞争力中的作用。拟议的研究旨在解决一些问题 关于生理转编辑功能和潜在兼职的许多悬而未决的问题 INS 超家族的功能。这些领域在真核生物中很大程度上尚未被探索,包括一个新的亚 许多单细胞真核病原体中编码的家族簇。反式编辑的治疗潜力 域尚未被利用,这代表了该领域的另一个重大差距,我们希望通过我们的解决方案来解决这一问题 计划的研究。从长远来看,将针对新型翻译保真机制的药物与 已知的核糖体靶向蛋白质合成抑制剂,例如氨基糖苷类药物,可能会更有效 治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karin M Musier-Forsyth其他文献

Karin M Musier-Forsyth的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karin M Musier-Forsyth', 18)}}的其他基金

Mechanism of selective packaging of primer tRNALys3 by HIV-1
HIV-1选择性包装引物tRNALys3的机制
  • 批准号:
    10258167
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
Mechanism of selective packaging of primer tRNALys3 by HIV-1
HIV-1选择性包装引物tRNALys3的机制
  • 批准号:
    10376353
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
Translational quality control by trans-editing domains
通过转编辑域控制翻译质量
  • 批准号:
    10406288
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
Translational quality control by trans-editing domains
通过转编辑域控制翻译质量
  • 批准号:
    10605294
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
Translational quality control by trans-editing domains
通过转编辑域控制翻译质量
  • 批准号:
    10822416
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
Translational quality control by trans-editing domains
通过转编辑域控制翻译质量
  • 批准号:
    10580273
  • 财政年份:
    2021
  • 资助金额:
    $ 38.35万
  • 项目类别:
RNA binding and packaging by retroviral Gag proteins
逆转录病毒 Gag 蛋白的 RNA 结合和包装
  • 批准号:
    10576298
  • 财政年份:
    2020
  • 资助金额:
    $ 38.35万
  • 项目类别:
RNA binding and packaging by retroviral Gag proteins
逆转录病毒 Gag 蛋白的 RNA 结合和包装
  • 批准号:
    10034983
  • 财政年份:
    2020
  • 资助金额:
    $ 38.35万
  • 项目类别:
RNA binding and packaging by retroviral Gag proteins
逆转录病毒 Gag 蛋白的 RNA 结合和包装
  • 批准号:
    10347332
  • 财政年份:
    2020
  • 资助金额:
    $ 38.35万
  • 项目类别:
Cellular Factors Critical for Initiation of HIV-1 Reverse Transcriptase
对 HIV-1 逆转录酶启动至关重要的细胞因素
  • 批准号:
    10393691
  • 财政年份:
    2014
  • 资助金额:
    $ 38.35万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 38.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了